$914.57
16.471.83%
At Close: -
$916.01
1.440.16%
After Hours: Jul 5, 6:27 PM EDT
15 minutes delayed
Eli Lilly and Co reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Eli Lilly and Co using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
LLY | Eli Lilly | $2.11 | — | — | — | $8.31B | — | — | — | 08/06/2024 | Get Alert |
LLY | Eli Lilly | $1.62 | $2.46 | $2.58 | 4.88% | $6.96B | $8.92B | $8.77B | -1.70% | 04/30/2024 | Get Alert |
LLY | Eli Lilly | $2.09 | $2.19 | $2.49 | 13.70% | $7.30B | $8.93B | $9.35B | 4.74% | 02/06/2024 | Get Alert |
LLY | Eli Lilly | $1.98 | -$0.15 | $0.10 | 166.67% | $6.94B | $8.95B | $9.50B | 6.13% | 11/02/2023 | Get Alert |
LLY | Eli Lilly | $1.25 | $1.99 | $2.11 | 6.03% | $6.49B | $7.58B | $8.31B | 9.66% | 08/08/2023 | Get Alert |
LLY | Eli Lilly | $2.62 | $1.73 | $1.62 | -6.36% | $7.81B | $6.86B | $6.96B | 1.46% | 04/27/2023 | Get Alert |
LLY | Eli Lilly | $2.49 | $1.78 | $2.09 | 17.42% | $8.00B | $7.33B | $7.30B | -0.38% | 02/02/2023 | Get Alert |
LLY | Eli Lilly | $1.77 | $1.92 | $1.98 | 3.12% | $6.77B | $6.91B | $6.94B | 0.46% | 11/01/2022 | Get Alert |
LLY | Eli Lilly | $1.87 | $1.69 | $1.25 | -26.04% | $6.74B | $6.70B | $6.49B | -3.16% | 08/04/2022 | Get Alert |
LLY | Eli Lilly | $1.87 | $2.13 | $2.62 | 23.00% | $6.81B | $6.68B | $7.81B | 16.92% | 04/28/2022 | Get Alert |
LLY | Eli Lilly | $2.75 | $2.19 | $2.49 | 13.70% | $7.44B | $6.90B | $8.00B | 15.94% | 02/03/2022 | Get Alert |
LLY | Eli Lilly | $1.54 | $1.68 | $1.94 | 15.48% | $5.74B | $5.70B | $6.77B | 18.82% | 10/26/2021 | Get Alert |
LLY | Eli Lilly | $1.89 | $1.92 | $1.87 | -2.60% | $5.50B | $6.65B | $6.74B | 1.35% | 08/03/2021 | Get Alert |
LLY | Eli Lilly | $1.75 | $2.14 | $1.87 | -12.62% | $5.86B | $7.02B | $6.81B | -3.05% | 04/27/2021 | Get Alert |
LLY | Eli Lilly | $1.73 | $2.35 | $2.75 | 17.02% | $6.11B | $7.29B | $7.44B | 2.06% | 01/29/2021 | Get Alert |
LLY | Eli Lilly | $1.48 | $1.71 | $1.54 | -9.94% | $5.48B | $5.91B | $5.74B | -2.86% | 10/27/2020 | Get Alert |
LLY | Eli Lilly | $1.50 | $1.56 | $1.89 | 21.15% | $5.64B | $5.76B | $5.50B | -4.53% | 07/30/2020 | Get Alert |
LLY | Eli Lilly | $1.33 | $1.48 | $1.75 | 18.24% | $5.09B | $5.51B | $5.86B | 6.35% | 04/23/2020 | Get Alert |
LLY | Eli Lilly | $1.33 | $1.51 | $1.73 | 14.57% | $6.44B | $5.90B | $6.11B | 3.63% | 01/30/2020 | Get Alert |
LLY | Eli Lilly | $1.39 | $1.40 | $1.48 | 5.71% | $6.06B | $5.50B | $5.48B | -0.42% | 10/23/2019 | Get Alert |
LLY | Eli Lilly | $1.50 | $1.45 | $1.50 | 3.45% | $6.36B | $5.59B | $5.64B | 0.84% | 07/30/2019 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-04-30 | $2.58 | $2.46 | 4.88 % |
Dec 2023 | 2024-02-06 | $2.49 | $2.19 | 13.7 % |
Sep 2023 | 2023-11-02 | $0.10 | $-0.15 | 166.7 % |
Jun 2023 | 2023-08-08 | $2.11 | $1.99 | 6.03 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-04-30 | $8.77B | $8.92B | -1.70 % |
Dec 2023 | 2024-02-06 | $9.35B | $8.93B | 4.74 % |
Sep 2023 | 2023-11-02 | $9.50B | $8.95B | 6.13 % |
Jun 2023 | 2023-08-08 | $8.31B | $7.58B | 9.66 % |
Eli Lilly and Co (LLY) is scheduled to report earnings on August 6, 2024. The last reported earnings were for reported on April 30, 2024 for Q1.
The Actual EPS was $2.58, which beat the estimate of $2.46.
The Actual Revenue was $8.8B, which missed the estimate of $8.9B.
Browse earnings estimates, EPS, and revenue on all stocks.